Amelia Kellar

Appearances

EXTERNAL VALIDATION OF INTESTINAL ULTRASOUND SCORES TO DETECT ENDOSCOPIC ACTIVITY IN CHILDREN AND ADULTS WITH CROHNS DISEASE: A PROSPECTIVE COHORT STUDY
Date
May 7, 2023
BACKGROUND: Anti-granulocyte macrophage-colony stimulating factor autoantibodies (anti-GM-CSF) have been associated with development of Crohn’s disease (CD) and complications at time of diagnosis. There are limited data on anti-GM-CSF as a prognostic biomarker in CD…
Speakers
Illya Aronskyy
Elizabeth Spencer
Amelia Kellar
Nanci Pittman
Marla Dubinsky
Icahn School of Medicine, Mount Sinai
Presenter
Michael T. Dolinger
Icahn School of Medicine at Mount Sinai Department of Pediatrics
EARLY ULTRASOUND RESPONSE AFTER BIOLOGIC THERAPY INDUCTION PREDICTS ENDOSCOPIC REMISSION IN PEDIATRIC CROHNS DISEASE
Date
May 8, 2023
BACKGROUND: Tumor necrosis factor inhibitors (TNFi) are a mainstay of pediatric Crohn’s disease (PCD) therapy; yet not all patients respond, and others lose response over time. Combination therapy with methotrexate may improve response; however, this has not been rigorously evaluated…
Presenter
Michael T. Dolinger
Icahn School of Medicine at Mount Sinai Department of Pediatrics
Speakers
Illya Aronskyy
Amelia Kellar
Elizabeth Spencer
Nanci Pittman
Marla Dubinsky
Icahn School of Medicine, Mount Sinai